‘More Promising Mesothelioma Clinical Trials than Ever Before,’ Says Expert

Mary Hesdorffer, APRN, expert mesothelioma nurse practitioner and executive director of the Mesothelioma Applied Research Foundation, stated recently at the organization’s board meeting, that mesothelioma patients today have many more options for clinical trials to choose from than ever before.

Alexandria, VA (PRWEB) July 31, 2014

During the July 2014 board meeting of the Mesothelioma Applied Research Foundation, mesothelioma expert and executive director of the Mesothelioma Applied Research Foundation, Mary Hesdorffer, APRN, stated that mesothelioma patients today have more promising clinical trials to choose from than ever before.

In her talk, she mentioned several trials that have been reporting increased survival and response rates. Some include novel radiation treatments, while the focus of others is within the field of immunotherapy. One trial, in particular, is looking very promising with a 69% durable response in a small group of patients. Ms. Hesdorffer stated that a new, larger trial currently underway is looking to confirm these results.

“A clinical trial is a unique opportunity for a patient to try something new and innovative that could have a very positive impact on the patient’s disease,” said Ms. Hesdorffer. “Having options is an important step forward in a disease that merely a decade ago was seen as hopeless,” she added.

Ms. Hesdorffer provides free consultations about clinical trials, as well as other issues pertaining to mesothelioma, as part of the Mesothelioma Applied Research Foundation’s patient services.

“While healthcare providers aren’t able to review all clinical trial options with their patients due to time constrains, at the Meso Foundation it is our job to spend the necessary time to go through all viable options while taking into consideration insurance coverage, stage of disease, histology and readiness to participate in a clinical trial,” added Ms. Hesdorffer.

Mary Hesdorffer, MS, APRN-BC, is a nurse practitioner with over 16 years of experience in mesothelioma treatment. She is an expert in clinical trials for mesothelioma and her work has been published in a variety of scientific journals.

The Mesothelioma Applied Research Foundation has recently released a downloadable brochure about mesothelioma clinical trials, which can also be requested by mail, and lists all mesothelioma clinical trials on its website.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards.

About the Mesothelioma Applied Research Foundation

The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer reviewed scientific research to establish effective treatments for mesothelioma and, ultimately, a cure for this extremely aggressive cancer. To date, the Foundation has awarded over $8.7 million to research. More information is available at http://www.curemeso.org.


For the original version on PRWeb visit: http://www.prweb.com/releases/2014/08/prweb12062719.htm

Marketing Maven Receives Small Business Association’s 8(a) Certification

Certification into the SBA’s 8(a) Business Development Program Provides Marketing Maven with Valuable Advantage in Federal Government Contracting

Los Angeles (PRWEB) July 31, 2014

Integrated marketing firm, Marketing Maven, announced that they became certified by the Small Business Administration (SBA) 8(a) Business Development Program on July 16, 2014.

The 8(a) program is designed to assist socially and economically disadvantaged entrepreneurs in gaining access to the massive federal government contracting market. The SBA also provides training and support as part of this nine-year business development program to help companies establish a solid foundation in government contracting.

Marketing Maven can now pursue federal government contracts leveraging opportunities set aside for 8(a) companies. Approval to enter the 8(a) Business Development Program is granted only after completing a rigorous review process to ensure applicants meet the standards for entering this coveted program. Paul Mazbanian, founder of Small Business Community Consultants, Inc. helped Marketing Maven prepare the SBA 8(a) certification, helping make Marketing Maven one of 785 companies in California as of July 21, 2014 to have this national minority status to compete for government contracts.

“Receiving our 8(a) certification is the product of a long process but one which we are sure will have a positive outcome for our company,” said Lindsey Carnett, CEO and president of Marketing Maven. “We are excited to provide our services to federal government agencies and be a part of the change they wish to see on a national level.”

In addition to their 8(a) certification, Marketing Maven also maintains the following certifications: Women Owned Small Business (WOSB), Disadvantaged Business Enterprise (DBE) and Women’s Business Enterprise (WBE) certified by the Women’s Business Enterprise National Council-West.

To learn more about Marketing Maven’s integrated marketing solutions, social media marketing and award-winning PR campaigns, visit http://www.marketingmavenpr.com.

About Small Business Community Consultants, Inc.

Small Business Community (SBC) Consultants was founded in 2007 to provide Small and Minority Owned companies the opportunity to grow their business through Government Contracting. For small business solutions, please visit http://www.sbclending.com/.

About Marketing Maven

Marketing Maven is an integrated LA marketing firm with offices in New York focusing on public relations, Hispanic marketing and social media. Their services aid national marketing campaigns and product launches with reputation management, organic SEO tracking, competitive analysis reports and online product reviews to help increase revenue. To learn more, please visit http://www.marketingmavenpr.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/08/prweb12062684.htm

Continue reading

Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk

Zoll, Kranz & Borgess, LLC, (ZKB), an experienced pharmaceutical and medical device litigation firm, is currently investigating claims of individuals who were diagnosed with cancer after a hysterectomy or myomectomy (removal of uterine fibroids) using a power morcellator device.

Toledo, Ohio (PRWEB) July 31, 2014

In a front-page story, the Wall Street Journal (7/30) reports that the pharmaceutical giant, Johnson & Johnson, is withdrawing its laparoscopic power morcellator due to data showing that it can spread undetected cancer. This important story has also been reported by Bloomberg News (7/31), Reuters (7/30), USA Today (7/31), the AP (7/30), the Pittsburgh Business Times (7/30) and TIME (7/30).

The morcellator tool is used during uterine procedures to, “slice up common uterine masses called fibroids, and uteruses themselves, into fragments so they can be removed in minimally invasive surgery.” (Wall Street Journal, 7/30)

J&J previously suspended the sale of new morcellators in April after the U.S. Food and Drug Administration issued a safety communication advising doctors not to use the tool. Specifically, FDA concluded that, “based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus.”

The FDA determined that approximately 1 in 350 women who are undergoing hysterectomy or myomectomy for fibroids have an unsuspected type of uterine cancer called uterine sarcoma. It further noted, “If laparoscopic power morcellation is performed in these women, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s likelihood of long-term survival.”

According to an article published in the Journal of the American Medical Association in March, more than 20,000 minimally invasive or robotic hysterectomies are done annually.

The law firm of Zoll, Kranz & Borgess, LLC (“ZKB”) devotes its practice to the field of pharmaceutical and medical device litigation. ZKB is dedicated to compelling companies to produce safer products. Injured clients and partnering attorneys from across the U.S. appreciate and rely upon over 70 years of combined experience in pharmaceutical mass torts and multidistrict litigation. ZKB’s experienced team includes a practicing physician-attorney and all the technology, knowledge and experience necessary to succeed in this complex legal field.

For more information about morcellators or if you were diagnosed with cancer after a hysterectomy or myomectomy (removal of uterine fibroids) using a power morcellator device, contact ZKB toll-free at (888) 841-9623 or visit the firm’s website at http://www.zkblaw.com. Initial consultations are always free and confidential.


Wall Street Journal (7/30) http://online.wsj.com/articles/johnson-johnson-to-call-for-voluntary-return-of-morcellators-1406754350

FDA News Release (4/17/14)


JAMA: Evaluating the Risks of Electric Uterine Morcellation (March 2014)


For the original version on PRWeb visit: http://www.prweb.com/releases/fibroid-hysterectomy/morcellator-cancer-risk/prweb12062687.htm

Continue reading

As Mobile Apps Evolve, Atlanta Mobile App Developers Ready to Meet the Challenge

Now What? Studio offers new tools designed to be at the forefront of next generation app development for small businesses.

Atlanta, GA (PRWEB) July 31, 2014

The fact that mobile app usage continues to skyrocket is no longer new news to most Atlanta small business owners. Indeed, many of them have embraced the idea of offering a mobile app to their customers. What is new however, nationwide, are the levels of interactivity being built into mobile apps, something that the founders of Now What? Studio, an Atlanta marketing company that specializes in mobile app development, says is driving businesses to rethink their current mobile apps.

“Mobile apps are becoming more and more useful,” says Now What? Studio co-founder William Colvard, “Recently Starbucks and Domino’s both added in-app ordering to their mobile apps and Target has just added a QR code function that allows mobile users to buy items from their flyers by simply scanning a code”

“And those are just three very recent examples’” he continues “What these innovations mean however, is that consumers are beginning to expect that level of functionality from local business apps as well. It’s great that their local pizza parlor has an app, but they now want to be able to order their dinner from it as well, just like Domino’s”.

Now What? Studio, a full-service Atlanta marketing company, has been offering their services as Atlanta mobile app developers for several years now, and according to fellow co-founder Ken Morris, the company has become one of the leading Atlanta business mobile app providers because their apps have always included innovations like these.

Says Morris, “Since day one, we have offered a robust in-app food ordering system to Atlanta restaurants and eateries, an excellent and secure shopping cart system for retailers and extensive multimedia functionality. As mobile app developers we never stop learning and experimenting. This allows us to develop the next gen technologies that consumers are looking for Atlanta small businesses to provide to them, via their mobile apps.”

To help more Atlanta small businesses take advantage of all that a fully interactive iPhone, Android, iPad, or HTML5 mobile app can provide for them, Now What? Studio is currently offering any company in the Atlanta area the chance to get a preview of a mobile app custom created for their business free of charge, with no obligation. To learn more about this special offer visit: http://offers.nowwhatstudio.com/mobile-app-development-atlanta/.

Now What? Studio is an Atlanta Mobile App Development company that makes innovative apps for iPhone, iPad, Android, and HTML5.

As a Full Service Atlanta Marketing Agency, Now What? Studio also specializes in Branding, Graphic Design, Website Design, Public Relations, and Social Media Marketing.

For the original version on PRWeb visit: http://www.prweb.com/releases/atlanta-app-development/iphone-mobile-app/prweb12062641.htm

Continue reading

Thermage for Loose Skin, Exilis for Body Shaping and Carboxytherapy for Stretch Marks are the Leading Procedures 2nd Quarter 2014 at Precision Aesthetics in NY

The trend towards more natural and minimally invasive procedures like Thermage, Exilis and Carboxytherapy continue through the second quarter at Precision Aesthetics in NY.

(PRWEB) July 31, 2014

Patients are choosing less invasive and more natural cosmetic treatments at Precision Aesthetics New York. Precision Aesthetics is New York’s leading Thermage, Carboxytherapy and Exilis provider for over 7 years. Over the past 12 years many of the new treatments that have evolved are more natural, and minimally invasive. The reason for growth in this sector is that although less invasive, many of these new procedures compare favorably to surgery. Thermage and Exilis compare favorably to a mini face-lift or liposuction for the body. “Before and after pictures of non-surgical procedures like Thermage and Exilis, show similar results to surgical procedures,” commented John Aslanian Practice manager at Precision Aesthetics. The favorable comparisons are even more apparent in before and afters of the popular mini face-lift compared to Thermage and Exilis. “Terrific results have been demonstrated for the face and every single part of the body,” continued John.

The worst outcome from Thermage or Exilis is that results may fall short of expectations. However, even that would be avoided given a proper consultation. Surgically, there is the possibility of scarring, lumpiness and loose skin after liposuction. Exilis is actually being used more and more to help with lumpiness after surgical liposuction. Carboxytherapy is another example of using the bodies natural processes for a cosmetic result. Every single cell in the body takes in oxygen and excretes carbon dioxide. That principle is utilized to increase circulation with minute injections of carbon dioxide to improve cellulite, stretch marks and dark under eye circles.

There are many additional natural and minimally invasive solutions that are proliferating. One example is PRP (protein rich plasma) or the so-called Dracula facelift. It is being used instead of Botox for smaller wrinkles. The procedure uses growth factors from blood versus the powerful neurotoxin, botox. The growth factors literally repair wrinkles vs. paralyzing the muscle with Botox. PRP is also used for overall facial rejuvenation. Cryotherapy facials improve the skin by increasing circulation to the face with alternating heat and cold. Another fascinating discovery was acoustic wave therapy, which was originally used for physical therapy to speed recovery of muscle injury. The acoustic waves deep stimulation causes the muscle to repair more quickly. The side effect was improved cellulite. This was ironically discovered by female athletes after doing physical therapy. Dr Zdinak and Precision Aesthetics were contacted by the manufacturer to investigate the loss of cellulite utilizing acoustic wave. One of the newest minimally invasive treatments utilize cold lasers, like Illumiwave, for hair growth, acne, and fat loss. Cold lasers are much less invasive than hot lasers. As the name implies, they are literally cold and do not produce any heat but still stimulate our cells with various positive outcomes.

The fact that patients are choosing minimally invasive more natural safer treatments is a great trend that will only continue to grow. Dr Lisa Zdinak, Chief Surgeon and Medical Director of Precision Aesthetics, has spent years bringing no less than 12 new technologies and products from various countries to the United States for her patients. She has put aside surgery to spend more time to research and bring the best natural and minimally invasive solutions for her patients. She is on the forefront of technologies like personal creams, utilizing patient’s own growth factors and other cutting-edge technologies we will be hearing more about in the future.

Precision Aesthetics is located at 10 West 74th St steps of Central Park West in a discreet private boutique setting for those seeking the ultimate in privacy. For more information, go to http://www.PrecisionAestheticsMD.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/07/prweb12057794.htm

Continue reading

Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 – New Research Report by MarketsandMarkets

The technological advancements and the increased government support in the form of funding are the factors that drive the nucleic acid isolation and purification market across the globe – http://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-purification-market-229978287.html.

(PRWEB) July 31, 2014

The “Nucleic Acid Isolation and Purification Market by Technology (Column based, Reagent based, Magnetic bead based), Consumables & Instruments, by Application (Plasmid DNA isolation, MIRNA isolation, Total RNA isolation), End users – Global Forecasts to 2018” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global nucleic acid isolation and purification market along with the estimates and forecasts of the revenue and share analysis.

This report studies the global nucleic acid isolation market over the forecast period of 2013 to 2018. This market is valued at an estimated $2,103.39 million in 2013.

For Further Inquiry: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=229978287

The report segments this market by technology, application, product, end user, and geography. The technology segments included in this report are column-based, magnetic bead-based, reagent-based, and other (anion exchange-based, glass fiber-based) for DNA and RNA isolation and purification. Of these, the column-based technology for DNA isolation and purification commands the largest share of the global market and is also poised to grow at the healthy CAGR between 2013 and 2018. However, magnetic bead-based technology for DNA isolation will grow at highest CAGR during the forecasted period. Use of purified form of DNA in research for various downstream processes is the primary growth driver of this technology segment.

The nucleic acid isolation and purification market is rapidly getting highly consolidated. For instance, in February 2014, Thermo Fisher Scientific acquired Life Technologies Corporations (U.S.), which strengthened its portfolio of reagents, consumables, instruments, and systems. In 2013, the top five players had a combined market share of over 90%. This makes it difficult for new players to differentiate their technology platforms and penetrate the market. Furthermore, there is a large variation in technology preference in different geographic and application segments. Low-cost reagent-based techniques for nucleic acid isolation and purification are still being preferred over kits and instrument-based techniques in key geographic segments of Asia and Latin America. Reagent-based techniques are also being preferred for specific applications like genomic DNA isolation. With such substantial difference in user preference for technologies and applications, it becomes important for market players to identify current market size and future market potential for each technology and application segment. This information will enable market players to make well-informed decisions about growth strategies in this highly competitive and evolved market.

Request for customization of report @ http://www.marketsandmarkets.com/requestCustomization.asp?id=229978287.

The global nucleic acid isolation and purification industry presents significant growth potential. Most players in this market are aiming to either diversify their product portfolios or expand their geographic presence to maintain their market shares. Between 2011 and 2013, entering into collaborative partnerships was an important growth strategy adopted by most players in the nucleic acid isolation and purification market.

This strategy was employed by players to gain immediate technological competency and widen their geographic presence. For instance in July 2013, QIAGEN partnered with Exosome Diagnostics Inc. (U.S.) to develop and commercialize high-performance sample preparation kits for the processing of nucleic acids from exosomes. This strategy was mainly adopted by Illumina, Inc. (U.S.), GE Healthcare (U.K.), Life Technologies (U.S.), QIAGEN (Netherlands), and Roche Applied Sciences (Germany).

Browse Related Reports:

Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) – Global Forecast to 2018


Dairy Herd Management Market by Product (Hardware, Systems & Software), Application (Feeding, Milking, Heat Stress, Animal Comfort, & Reproduction Management) & by End User (Small, Large & Cooperative Dairy Farms) – Global Forecast to 2018


About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.


Mr. Rohan

North – Dominion Plaza,

17304,Preston Road,

Suite 800, Dallas, TX 75252

Tel: +1-888-600-6441

Email: sales(at)marketsandmarkets(dot)com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology.

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets.

For the original version on PRWeb visit: http://www.prweb.com/releases/naip/market/prweb12039909.htm

Continue reading

Drake Chiropractic Offers Special to New Patients in Wichita

Drake Chiropractic in Wichita, Kansas offers a special to new patients for a limited time.

Wichita, KS (PRWEB) July 31, 2014

Dr. Jeff Drake at Drake Chiropractic is one of the most respected and well known chiropractors in the area and he has really made a business out of helping people improve and feel better. He is constantly working with new and return patients to improve treatments, get better results, and lead pain free lives. Those who are in pain or experience daily suffering should definitely contact Dr. Drake!

The good news is for those who have never visited Drake Chiropractic, Dr. Drake is offering a new patient special currently that is definitely motivation to get in to the office and get started on the path towards feeling better. The new patient special is a great way to get introduced to chiropractic treatment so call now and schedule a free consultation; it might be surprising just how much help they can offer for any number of pains or problems.

This new patient special is really a great deal because it is definitely going to at least provide a starting point for dealing with pain. Not all aches and pains can be treated, but most can, so this is a free opportunity to come in and have a consultation to decide if this treatment is the right treatment. If Dr. Drake decides that treatment is the right course, he can help form a treatment plan right on the spot and in most cases can provide treatment that same day! It’s possible to start feeling better in just one day!

If this free special isn’t enough to get Wichita residents in to Drake Chiropractic, then nothing will, so give them a call today and schedule a free consultation. No matter what pain someone is experiencing, what is causing it, or how much they are suffering, Dr. Drake and his staff can make things better. Now is the opportunity to take control of life and start working to feel better and with Dr. Drake’s help it is absolutely possible to lead a pain free and comfortable life again. Whether it’s long term suffering or a recent injury, there will never be a better time than now to get it treated and start feeling better again. So get in touch with them today.

For more info:

Drake Chiropractic

154 S Rock Rd Wichita, KS 67207

(316) 651-0156


For the original version on PRWeb visit: http://www.prweb.com/releases/2014/07/prweb12056674.htm

Continue reading

Sunrise Technologies Celebrates 20 Years of Implementing Great Ideas

Sunrise Technologies celebrates 20 years of business.
Winston-Salem, NC (PRWEB) July 31, 2014 Sunrise Technologies, the Microsoft Dynamics AX Distribution Partner of the Year, is proud to be celebrating 20 years of business this month.
John Pence … Continue reading

ASPG Expands International Reach with Representation in the United Kingdom and Ireland

Advanced Software Products Group’s (ASPG) latest announced addition to its International representation offers increased data protection and enterprise software solution options for United Kingdom and Ireland.

Naples, FL (PRWEB) July 31, 2014

Advanced Software Products Group, Inc. is pleased to announce the addition of Inspired Solutions Ltd. as their distribution partner for the United Kingdom and Ireland. Inspired Solutions Ltd. will offer the full line of ASPG software solutions, including flagship products such as MegaCryption for z/OS cryptography, ReACT for self-service password reset, and ERQ for RACF administration and reporting.

Inspired Solutions Ltd. is a Manchester based company providing cost-effective software for both mainframe and distributed platforms for the past 17 years. With knowledge and experience in performance management, capacity planning, and data security, Inspired Solutions is a natural fit for the ASPG products.

With their corporate headquarters located in Naples, Florida, USA, ASPG, Inc. has expanded rapidly into the global market with dedicated international representation in 24 countries.

ASPG’s clients span all industries including state and federal government, healthcare, finance, education, transportation, manufacturing & retail. Additionally, ASPG is proud to serve the majority of the GLOBAL 1000 data centers, which have selected ASPG software solutions to increase productivity, protect data, and solve critical issues in their IT environments.


For nearly 30 years, ASPG, an IBM and Microsoft partner, has produced award-winning software for data centers worldwide, specializing in data security, storage administration, and systems productivity. ASPG is pleased to provide solutions for a majority of the GLOBAL 1000 data centers.

For more information about ASPG, please contact our Sales Team by phone at 800-662-6090 (Toll-Free) or 239-649-1548 (US/International), 239-649-6391 (fax) or email at aspgsales(at)aspg(dot)com. You can also visit the ASPG website at http://www.aspg.com.

Press Contact:

David Vertin, Director of Marketing

Advanced Software Products Group, Inc.

3185 Horseshoe Drive South, Naples, FL 34104

Phone: 239.649.1548

Fax: 239.649.6391

Email: david.vertin(at)aspg(dot)com

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/08/prweb12062361.htm

Continue reading

Investing in Agriculture – High Returns, Asset Secure and with Low Volatility – Liquid Investments

Join Liquid Investments in Brazil to find out why global agriculture is rapidly approaching a tipping point, and by 2028 nearly all the agrarian land in stable regions world-wide will be in cultivation. Fast expanding deserts, lower water tables and the impact of climate change are all playing their part.

(PRWEB UK) 31 July 2014

The inevitability of rising consumer demand together with shrinking levels of available farmland will drive the value of agricultural land and food prices much higher:

  •     A 70% expansion in global food production will be needed by 2050, and food prices are forecast to rise by 60%
  •     The demand for more protein in developing economies is altering the strategic balance of what is grown, and where
  •     A complex and growing issue is access to fresh water. Brazil has the world’s largest freshwater supplies
  •     The global geopolitical environment has deteriorated significantly in 2014, with implications for long-term food security
  •     Farmland the size of California is being lost every three years due to erosion, higher levels of salt in the soil and other forms of land degradation.

With increasing uncertainty in mainstream financial markets, join Liquid Investments this September in Brazil on their annual Plantation Tour and Primal Investing Summit. Liquid’s Chief Guest will be Jim Rogers, investment guru and co-founder of the Quantum Fund, and who is widely considered as one of the most astute investors Wall Street has ever known.

Already a global powerhouse, and soon to become both the world’s fifth largest economy and consumer market, Brazil will also be the largest exporter of agricultural foodstuffs by 2020. Find out about the exciting agricultural investment opportunities in Brazil with alternative asset specialists, Liquid Investments at their Tour and Investment Summit. Find out more about the Tour and Summit.

If you can’t make it to Brazil, you can find out what Liquid’s current investment options are by:

  • Email: tours(at)liquid-investments(dot)com
  • Call back request.
  • Telephone: +44 (0) 20 7084 7421

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/07/prweb12056911.htm

Continue reading